CD70 and renal cell carcinoma: Additionally, three RCC lines were used: 786-O-FG (CD70high), ACHN-FG (CD70low), and a CRISPR-Cas9-engineered CD70 knockout line, 786-O-FGCD70−/− (Figures 3B and S3B).